Kala Pharmaceuticals, Inc.

Q4 2023 13F Holders

Symbol
KALA
CUSIP
483119202
Type
Equity
Class
COM NEW
Num filings
27
Total reported value, excl. options
$3.69 M
Manager Report Date Value ($000) Shares Option Type